Wellpoint: Oppenheimer Funds’ Largest Healthcare Stock Holding in Q3

Wall St. Watchdog reveals information regarding Oppenheimer Funds, Inc.’s top holdings in the Healthcare sector for the quarter ending September 30th, 2011. The firm held 121 stocks in the Healthcare sector at the end of the quarter with an aggregate market value of $5.387 billion.

  • Wellpoint Inc. (NYSE:WLP): On 06/30/2011, Oppenheimer Funds, Inc. reported holding 9,139,920 shares with a market value of $719,951,468. This comprised 1.18% of the total portfolio. On 09/30/2011, Oppenheimer Funds, Inc. reported holding 8,692,358 shares with a market value of $567,437,120. This comprised 1.16% of the total portfolio. The net change in shares for this position over the two quarters is -447,562. About Company: WellPoint Inc. is a health benefits company. The Company provides health benefits, dental and vision benefits, pharmacy benefits, life insurance, and life and disability insurance benefits. WellPoint operations include Blue Cross and Blue Shield plans.
  • Bristol-myers Squibb Company (NYSE:BMY): On 06/30/2011, Oppenheimer Funds, Inc. reported holding 11,612,333 shares with a market value of $336,293,153. This comprised 0.55% of the total portfolio. On 09/30/2011, Oppenheimer Funds, Inc. reported holding 13,880,281 shares with a market value of $435,563,206. This comprised 0.89% of the total portfolio. The net change in shares for this position over the two quarters is 2,267,948. About Company: Bristol-Myers Squibb Company is a global biopharmaceutical company that discovers, develops, manufactures and sells pharmaceutical and nutritional products. The Company’s products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psychiatric disorders.
  • Allergan Inc. (NYSE:AGN): On 06/30/2011, Oppenheimer Funds, Inc. reported holding 4,390,407 shares with a market value of $365,501,383. This comprised 0.6% of the total portfolio. On 09/30/2011, Oppenheimer Funds, Inc. reported holding 4,205,267 shares with a market value of $346,429,884. This comprised 0.71% of the total portfolio. The net change in shares for this position over the two quarters is -185,140. About Company: Allergan, Inc. is a multi-specialty health care company that discovers, develops and commercializes pharmaceuticals, biologics and medical devices. The Company develops products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological and other specialty markets in countries around the world.
  • Celgene Corporation (NASDAQ:CELG): On 06/30/2011, Oppenheimer Funds, Inc. reported holding 6,734,421 shares with a market value of $406,220,273. This comprised 0.67% of the total portfolio. On 09/30/2011, Oppenheimer Funds, Inc. reported holding 4,932,188 shares with a market value of $305,351,758. This comprised 0.62% of the total portfolio. The net change in shares for this position over the two quarters is -1,802,233. About Company: Celgene Corporation is a global biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases.
  • Pfizer Inc. (NYSE:PFE): On 06/30/2011, Oppenheimer Funds, Inc. reported holding 14,351,015 shares with a market value of $295,630,914. This comprised 0.49% of the total portfolio. On 09/30/2011, Oppenheimer Funds, Inc. reported holding 15,000,836 shares with a market value of $265,214,785. This comprised 0.54% of the total portfolio. The net change in shares for this position over the two quarters is 649,821. About Company: Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company’s products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.
  • Abbott Laboratories (NYSE:ABT): On 06/30/2011, Oppenheimer Funds, Inc. reported holding 5,116,015 shares with a market value of $269,204,704. This comprised 0.44% of the total portfolio. On 09/30/2011, Oppenheimer Funds, Inc. reported holding 5,047,645 shares with a market value of $258,136,562. This comprised 0.53% of the total portfolio. The net change in shares for this position over the two quarters is -68,370. About Company: Abbott Laboratories discovers, develops, manufactures, and sells a broad and diversified line of health care products and services. The Company’s products include pharmaceuticals, nutritional, diagnostics, and vascular products. Abbott markets its products worldwide through affiliates and distributors.
  • Aetna Inc. (NYSE:AET): On 06/30/2011, Oppenheimer Funds, Inc. reported holding 6,744,917 shares with a market value of $297,383,392. This comprised 0.49% of the total portfolio. On 09/30/2011, Oppenheimer Funds, Inc. reported holding 6,967,069 shares with a market value of $253,183,289. This comprised 0.52% of the total portfolio. The net change in shares for this position over the two quarters is 222,152. About Company: Aetna Inc. is a diversified health care benefits company that provides healthcare and related benefits, serving health care members, dental members, and group insurance customers. The Company offers medical, pharmacy, dental, behavioral health, group life and disability plans, and medical management capabilities and health care management services for Medicaid plans.
  • Humana Inc. (NYSE:HUM): On 06/30/2011, Oppenheimer Funds, Inc. reported holding 3,098,790 shares with a market value of $249,576,549. This comprised 0.41% of the total portfolio. On 09/30/2011, Oppenheimer Funds, Inc. reported holding 3,412,808 shares with a market value of $248,213,537. This comprised 0.51% of the total portfolio. The net change in shares for this position over the two quarters is 314,018. About Company: Humana Inc. is a managed health care company with medical members located in the United States and Puerto Rico. The Company offers coordinated health care through health maintenance organizations, preferred provider organizations, point-of-service plans, and administrative services products. Humana offers its products to employer groups, government-sponsored plans, and individuals.
  • Zimmer Holdings Inc. (NYSE:ZMH): On 06/30/2011, Oppenheimer Funds, Inc. reported holding 3,382,845 shares with a market value of $213,795,807. This comprised 0.35% of the total portfolio. On 09/30/2011, Oppenheimer Funds, Inc. reported holding 3,288,844 shares with a market value of $175,887,376. This comprised 0.36% of the total portfolio. The net change in shares for this position over the two quarters is -94,001. About Company: Zimmer Holdings, Inc. designs, develops, manufactures, and markets orthopaedic and dental reconstructive implants, spinal implants, trauma products and related surgical products. The Company also provides other healthcare related services. Zimmer markets its products in the United States and other countries around the world.
  • Baxter International Inc. (NYSE:BAX): On 06/30/2011, Oppenheimer Funds, Inc. reported holding 3,337,577 shares with a market value of $199,219,967. This comprised 0.33% of the total portfolio. On 09/30/2011, Oppenheimer Funds, Inc. reported holding 3,054,368 shares with a market value of $171,472,218. This comprised 0.35% of the total portfolio. The net change in shares for this position over the two quarters is -283,209. About Company: Baxter International Inc. develops, manufactures, and markets products and technologies related to hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. The Company’s products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors’ offices, and research laboratories.

(Note: Data regarding Oppenheimer Funds, Inc.’s stock holdings are sourced from whalewisdom.com. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>